Presentation Prolonged Clopidogrel Use After BMS and DES Placement: The VA Drug-Eluting Stent Study Presenter: David P. Faxon June 08, 2012 REGISTER for free or LOG IN to view this content DES/BRS/DCB CAD Pharma Factoid Up Next Presentation Impact of Gender on 3-Month Outcome and Left Ventricular Remodeling After Transfemoral TAVR Presenter: Verena Stangl June 08, 2012 More slides + Presentation The Risk of Carotid Stenting (CAS) Compared with Endarterectomy (CEA) Is Greatest in Patients Treated Within 7 Days of Symptoms Presenter: Barbara Rantner June 11, 2012 Presentation Use of Diagnostic Imaging Studies and Associated Radiation Exposure for Pts Enrolled in Large Integrated Health Care Systems, 1996-2010 Presenter: Rebecca Smith-Bindman June 12, 2012 We Recommend
Presentation Impact of Gender on 3-Month Outcome and Left Ventricular Remodeling After Transfemoral TAVR Presenter: Verena Stangl June 08, 2012
Presentation The Risk of Carotid Stenting (CAS) Compared with Endarterectomy (CEA) Is Greatest in Patients Treated Within 7 Days of Symptoms Presenter: Barbara Rantner June 11, 2012
Presentation Use of Diagnostic Imaging Studies and Associated Radiation Exposure for Pts Enrolled in Large Integrated Health Care Systems, 1996-2010 Presenter: Rebecca Smith-Bindman June 12, 2012